Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

被引：4
|
作者：
Mahajan, Sudhir [1 ]
Avasthi, Ajit [1 ]
Grover, Sandeep [1 ]
Chawla, Yogesh K. [2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Psychiat, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh 160012, India
来源：
PSYCHOTHERAPY AND PSYCHOSOMATICS | 2014年 / 83卷 / 05期
关键词：
D O I：
10.1159/000358527
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：308 / 309
页数：2
相关论文
共 50 条
  • [21] Interferon-alpha plus ribavirin combination therapy for the treatment of chronic hepatitis C in interferon non-responders
    Hasan, F
    Asker, H
    Al Shamali, M
    Al Kalaoui, M
    Al Nakib, B
    [J]. HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1642 - 1644
  • [22] Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Midha, Vandana
    Sood, Ajit
    Syed, Hissar
    Sood, Neena
    Kumar, Manoj
    Sarin, Shiv K.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A13 - A13
  • [23] Effect of interferon-alpha with glutathione combination therapy for patients with chronic hepatitis C
    Yokogawa, T
    Nakjima, S
    Habu, D
    Takeda, T
    Nishiguchi, S
    Shiomi, S
    Seki, S
    Kuroki, T
    [J]. HEPATOLOGY, 1998, 28 (04) : 704A - 704A
  • [24] Effectiveness of varied dose of pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
    Midha, V.
    Sood, A.
    Hissar, S. S.
    Sood, N.
    Kumar, M.
    Sarin, S. K.
    [J]. PROCEEDINGS OF THE 16TH CONFERENCE OF THE ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER, 2006, : 1 - +
  • [25] Outcomes of treatment of hepatitis C cirrhosis with pegylated interferon-alpha and ribavirin
    Kong, J.
    Kontorinis, N.
    Studd, C.
    Tarquinio, L.
    Nazareth, S.
    McInerney, M.
    Cheng, W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A293 - A294
  • [26] Restoration of natural killer cell activity by pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C patient
    Nakamura, Ikuo
    Asano, Takeharu
    Asabe, Shinichi
    Ando, Mayumi
    Sano, Takatomo
    Miyata, Yuki
    Taira, Junichi
    Sugimoto, Katsutoshi
    Imai, Yasuharu
    Moriyasu, Fuminori
    Imawari, Michio
    [J]. HEPATOLOGY RESEARCH, 2015, 45 (01) : 107 - 112
  • [27] Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
    Joshita, Satoru
    Shirahata, Kumiko
    Yazaki, Yoshikazu
    Okaniwa, Shinji
    Nakamura, Yoshiyuki
    Kimura, Takefumi
    Noami, Sugiko
    Horigome, Reiko
    Yagi, Hikaru
    Ito, Nobuo
    Yamazaki, Asami
    Akahane, Yuki
    Umemura, Takeji
    Yoshizawa, Kaname
    Tanaka, Eiji
    Ota, Masao
    [J]. HEPATOLOGY RESEARCH, 2013, 43 (07) : 801 - 807
  • [28] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
    Carmen Sorina Martin
    Luminita Nicoleta Ionescu
    Carmen Gabriela Barbu
    Anca Elena Sirbu
    Ioana Maria Lambrescu
    Ioana Smarandita Lacau
    Doina Ruxandra Dimulescu
    Simona Vasilica Fica
    [J]. BMC Endocrine Disorders, 14
  • [29] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
    Martin, Carmen Sorina
    Ionescu, Luminita Nicoleta
    Barbu, Carmen Gabriela
    Sirbu, Anca Elena
    Lambrescu, Ioana Maria
    Lacau, Ioana Smarandita
    Dimulescu, Doina Ruxandra
    Fica, Simona Vasilica
    [J]. BMC ENDOCRINE DISORDERS, 2014, 14
  • [30] Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
    Rashed, Yasser K.
    Khalaf, Fatma A.
    Kotb, Sobhy E.
    [J]. CLINICAL AND EXPERIMENTAL PEDIATRICS, 2020, 63 (02) : 52 - 55
12345